2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$8.96+$0.04 (+0.51%)
Price as of Jul 14, 2026 4:33 AM EDT- $1.5BMarket Cap
- 27.83%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$8.96+$0.04 (+0.51%)
NVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.91 | ||
Change | -$0.42 (-4.50%) | ||
Open | $9.13 | ||
High | $9.27 | ||
Low | $8.80 | ||
Previous Close | $9.33 | ||
Volume | 3,855,264 | ||
30-Day Average Volume | 4,511,334 | ||
1-Week Change | -4.71% | ||
1-Month Change | 0.34% | ||
1-Year Change | 27.83% | ||
3-Year Change | -3.57% | ||
5-Year Change | -95.16% | ||
Fundamentals | |||
Shares Outstanding | 164.4M | ||
Total Assets | $1.0B | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $42.2M | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$33.7M | ||
EBIT | -$4.8M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $508.4M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -938 | ||
Enterprise Value/Revenue | 38 | ||
P/B | -11 | ||
P/E | -156 | ||
PEG | 1 | ||
Price/Free Cash Flow | -46 | ||
Price/Operating Cash Flow | -47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/13/2007 | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 05/10/2019 | ||
Earnings & Revenue